Signal to cut-off (S/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship?

Braz J Infect Dis. 2010 Mar-Apr;14(2):147-52. doi: 10.1590/s1413-86702010000200006.

Abstract

Background: Polymerase chain reaction (PCR) methods play an essential role in providing data related to diagnosis, monitoring and treatment of hepatitis C virus (HCV) infection. EIA results are reported as ''reactive'' or ''non reactive'' and EIA S/CO ratio may also be reported as ''high'' or ''low.'' This study aimed to evaluate the performance of a real-time RT-PCR and assess whether there is relationship between S/CO and PCR results.

Study design and methods: Sera from blood donors were analyzed by Enzyme-Linked Immunosorbent Assay (ELISA) and RT-PCR assay to detect HCV infection.

Results: The RT-PCR assay to genotypes 1a/b showed an acceptable linear response in serial dilutions. The samples were divided into two groups based on their serological results: group A--S/CO ratio < 3 (60 samples) and group B--S/CO ratio > 3 (41 samples). Viral loads were confirmed positive in group B samples in 90%, and in group A samples were confirmed positive in only 13% by RT-PCR.

Conclusion: The methodology used was able to detect the presence of RNA-HCV genotype I in 90% of the samples serologically positive in group B. All negative samples were sent to search for other genotypes of HCV (genotypes 2-6) and were confirmed as negative. These data suggests that these negative samples may have HCV RNA viral load below the detection limit of our test (310 IU/ mL), or a false positive result in serological test, or spontaneous viral clearance occurred.

Publication types

  • Evaluation Study

MeSH terms

  • Blood Donors
  • Enzyme-Linked Immunosorbent Assay / methods
  • Genotype
  • Hepacivirus / genetics*
  • Hepacivirus / immunology
  • Hepatitis C / diagnosis*
  • Hepatitis C Antibodies / blood
  • Humans
  • Polymerase Chain Reaction / methods
  • RNA, Viral / analysis*
  • Reproducibility of Results
  • Reverse Transcriptase Polymerase Chain Reaction / methods*
  • Viral Load

Substances

  • Hepatitis C Antibodies
  • RNA, Viral